Investor Presentaiton

Clear strategic plan to drive robust and value-enhancing growth 1 Existing royalties Acquire existing royalties on market- leading or late-stage development therapies with high commercial potential 2 Synthetic royalties / R&D funding Acquire newly-created royalties on approved or late-stage development therapies with strong proof of concept and high commercial potential 3 Launch & development capital(1) Additional funding in exchange for long-term payment streams 4 5 ROYALTY PHARMA 1. Including equity investments. M&A related Acquire royalties by facilitating M&A transactions Adjacencies Leverage team's capabilities in business adjacencies 8

View entire presentation